Tel. +1 301 453 6100
Fax +1 301 476 4851

Susan E. McBee is a registered patent attorney, and is recognized by Chambers and Partners USA as a leader in the field of intellectual property law. Susan is experienced in patent and trademark portfolio management for large Fortune 500 companies engaged in chemical, biotechnology, pharmaceutical, neutraceutical, and engineering fields, including agricultural chemistry, polymer chemistry, fermentation and extraction of proteins, food additives and processes, small molecule chemistry, genetic engineering, biotechnology, medical devices, metallurgy, packaging materials, electronic materials and associated methods of manufacture and use.

She also has extensive experience with both ex parte reexamination and inter partes review proceedings at the U.S. Patent and Trademark Office (USPTO) representing both patentees and third party requestors. She often is involved in IP due diligence during acquisitions and licensing negotiations involving her clients.

Susan’s prior career experience includes owning and operating a patent search company and working as a patent examiner at the USPTO in the field of polymer chemistry/light sensitive materials.

Professional Involvement
  • American Bar Association
  • American Intellectual Property Lawyers Association
  • Frederick County Bar Association
  • Chambers USA – America’s Leading Lawyers for Business: Listed in the area of Intellectual Property (2009-2015)
  • Washingtonian Magazine: Listed in Washingtonian Magazine as a “Top IP Lawyer” (2013-2014)
  • “Bioscience Firms Integral to Economy,” The Frederick News-Post (April 28, 2014).
  • “Attorneys React to High Court’s Gene Patent Ruling,” Law360 (June 13, 2013).
  • “The Supreme Court Should be Mindful of Naturally Derived Products Other Than Nucleic Acids When Defending Myriad,” SCOTUS blog (Co-Author) (February 07, 2013).
  • “Bilski’s Impact on Medical Method Patents,” Intellectual Asset Management (Co-Author) (July 01, 2011).
Speaking Engagements
  • “Myriad Ruling Impact: How Will Human Gene Patent Decision Affect Biotech Industry and Patients?,” International Business Times – Tech (June 14, 2013).
  • George Mason University School of Law, J.D. 1996, with High Honors.
  • Alderson-Broaddus College, B.S. Chemistry 1987, cum laude.
Bar Admissions
  • District of Columbia, 1998
  • Maryland, 1996
  • United States Patent and Trademark Office, 1995
Court Admissions
  • United States Court of Appeals for the Federal Circuit